Sign In
Get Clay Free →

Suggestions

    Adel Nada

    Co-founder and CEO at GentiBio

    Adel Nada is a prominent biotech executive and serial entrepreneur with extensive experience in the pharmaceutical and biotechnology industries. He is currently the Co-founder, President, and CEO of GentiBio, a biotherapeutics company focused on developing engineered regulatory T cells for treating autoimmune and inflammatory diseases.1

    Professional Background

    Education and Early Career: Adel Nada received his medical degree from Alexandria University in Egypt and later obtained a master's degree in clinical research from Rush University in Chicago. He completed advanced studies in drug development at UCSF and the University of Basel, and is a Member of the Faculty of Pharmaceutical Medicine in the UK.1

    Industry Experience: Prior to founding GentiBio, Dr. Nada held several executive positions in various biotech and pharmaceutical companies:

    • Chief Medical Officer at Casebia Therapeutics
    • Vice President and Head of Clinical Development at Intellia Therapeutics
    • Vice President of Immunotherapy at Caladrius Biosciences
    • Senior Medical Director at Baxter Healthcare
    • Various senior positions at Abbott Laboratories

    Current Roles

    In addition to his position at GentiBio, Adel Nada is involved in several other ventures:

    • Co-founder and Executive Chairman of Trutina and FytonBio
    • Board Director at Alia Therapeutics
    • Scientific Advisory Board Member at Vycellix

    Expertise and Achievements

    Dr. Nada has over 15 years of experience leading translational and immunology programs for experimental and approved therapies. His work spans small and large molecules, as well as engineered immune cell products, including regulatory T cell (Treg) therapies.1 At GentiBio, he successfully led the company through two rounds of equity financing and secured the first transformative deal with a large pharmaceutical company in the Treg space.2

    Personal Interests

    Outside of his professional life, Adel Nada is passionate about making a difference in patients' lives using advanced technologies. He is also an avid runner and photographer.3

    Related Questions

    What are Adel Nada's key achievements at GentiBio?
    How did Adel Nada transition from a medical career to biotech leadership?
    What inspired Adel Nada to co-found GentiBio?
    What are the main projects Adel Nada has worked on at Alia Therapeutics?
    How has Adel Nada's experience at Intellia Therapeutics influenced his career?
    Adel Nada
    Adel Nada, photo 1
    Adel Nada, photo 2
    Get intro to Adel
    Add to my network

    Experience

    Co-founder and CEO at GentiBio (May 2020 - Present)
    Board Director at Alia Therapeutics (March 2023 - Present), Scientific Advisory Board Member at Vycellix (April 2019 - Present), Chief Medical Officer at Casebia Therapeutics (Oct 2018 - Sep 2019); Vice President & Head of Clinical Development at Intellia Therapeutics, Inc. (July 2015 - Sep 2018)

    Education

    M.D. from Alexandria University (1988 - 1994); M.S. from Rush University (2001 - 2003); Diplomas from University of California, San Francisco, and Universität Basel

    Location

    Boston, Massachusetts, United States